Our Story
The beginning
Seeds in Freiburg, Germany
Bioelectrix traces its roots to the University of Freiburg, where our founders explored how subtle electrical cues influence cell behavior and tissue repair.
At Bioelectrix, our journey began with a simple question: what if we could help the body heal itself faster using electricity?
For most people, a small wound is a minor inconvenience. But for millions worldwide even a small wound can become serious and sometimes life-threatening.
When we began studying this challenge, we found that the body already uses electricity to support healing.
To influence skin cells and support healing, electrical stimulation must be gentle and continuous over longer periods. Traditional electrode materials, such as metals used in many medical devices, are not well suited for this. Over time, they can trigger unwanted chemical reactions, including gas formation or pH changes, that may harm sensitive wound tissue.
That is the problem we set out to solve.
Click to view in fullscreen
Bridging the gap
Where Bioelectronics Meets Healing
After years of research, we developed a novel way to deliver stable, controlled electrical stimulation to tissue.
Our work showed that cells can sense electrical signals and move in a coordinated direction. In lab models of skin wounds, stimulation helped cells close wound gaps up to three times faster than untreated samples, even under challenging conditions such as diabetic-like cells or disrupted cell communication.
These early results support the potential for our technology to become a real medical solution for improved wound healing.
Mission
Where we stand today
Turning a scientific breakthrough into a medical treatment takes more than promising lab results. It must be tested in tissue that closely reflects real patients.
That is why Bioelectrix is studying its technology in donated human skin from surgical procedures. These models let us measure wound healing in real human tissue under controlled conditions.
Human skin is far more complex than lab-grown cell layers. It includes different cell types, natural tissue structure, and biological barriers that better represent the environment where a future medical device needs to work.
In these human skin models, controlled electrical stimulation has shown faster wound closure than untreated controls. These results strengthen our confidence that Bioelectrix’s technology can move from early research toward clinical use.
The present
Building Bioelectrix
We are headquartered in Gothenburg, Sweden, with strong ties to Germany through our founders and the origins of the technology. We partner with care teams and researchers to refine usability and build evidence, starting with diabetic foot ulcers.
Becoming
With the support of Chalmers Ventures, our wonderful advisory board and close conversations with clinicians we founded Bioelectrix to bridge academic excellence with day-to-day care.
Our approach is pragmatic: design with nurses and physicians, validate with data, and communicate with humility.
What Drives Us
Scientific Excellence
We translate deep biomedical research into tools that stand up to scrutiny. If we can’t support it, we won’t say it.
Human Impact
Collaboration
We’re fortunate to collaborate with clinicians and researchers across Sweden and Germany and to be supported by Chalmers Ventures. Their belief in careful, evidence-first innovation helps us keep the bar high.